Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 2
1982 3
1983 4
1984 2
1985 6
1987 5
1988 4
1989 5
1990 7
1991 10
1992 6
1993 6
1994 14
1995 14
1996 19
1997 20
1998 13
1999 14
2000 19
2001 21
2002 33
2003 29
2004 46
2005 51
2006 77
2007 70
2008 100
2009 101
2010 117
2011 178
2012 221
2013 215
2014 267
2015 283
2016 342
2017 365
2018 452
2019 586
2020 697
2021 819
2022 1026
2023 1047
2024 342

Text availability

Article attribute

Article type

Publication date

Search Results

6,847 results

Results by year

Filters applied: . Clear all
Page 1
Cilia-related diseases.
Ren Z, Mao X, Wang S, Wang X. Ren Z, et al. J Cell Mol Med. 2023 Dec;27(24):3974-3979. doi: 10.1111/jcmm.17990. Epub 2023 Oct 13. J Cell Mol Med. 2023. PMID: 37830491 Free PMC article. Review.
Bacteria-derived nanovesicles enhance tumour vaccination by trained immunity.
Liu G, Ma N, Cheng K, Feng Q, Ma X, Yue Y, Li Y, Zhang T, Gao X, Liang J, Zhang L, Wang X, Ren Z, Fu YX, Zhao X, Nie G. Liu G, et al. Among authors: ren z. Nat Nanotechnol. 2024 Mar;19(3):387-398. doi: 10.1038/s41565-023-01553-6. Epub 2023 Dec 5. Nat Nanotechnol. 2024. PMID: 38052943
Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition).
Zhou J, Sun H, Wang Z, Cong W, Zeng M, Zhou W, Bie P, Liu L, Wen T, Kuang M, Han G, Yan Z, Wang M, Liu R, Lu L, Ren Z, Zeng Z, Liang P, Liang C, Chen M, Yan F, Wang W, Hou J, Ji Y, Yun J, Bai X, Cai D, Chen W, Chen Y, Cheng W, Cheng S, Dai C, Guo W, Guo Y, Hua B, Huang X, Jia W, Li Q, Li T, Li X, Li Y, Li Y, Liang J, Ling C, Liu T, Liu X, Lu S, Lv G, Mao Y, Meng Z, Peng T, Ren W, Shi H, Shi G, Shi M, Song T, Tao K, Wang J, Wang K, Wang L, Wang W, Wang X, Wang Z, Xiang B, Xing B, Xu J, Yang J, Yang J, Yang Y, Yang Y, Ye S, Yin Z, Zeng Y, Zhang B, Zhang B, Zhang L, Zhang S, Zhang T, Zhang Y, Zhao M, Zhao Y, Zheng H, Zhou L, Zhu J, Zhu K, Liu R, Shi Y, Xiao Y, Zhang L, Yang C, Wu Z, Dai Z, Chen M, Cai J, Wang W, Cai X, Li Q, Shen F, Qin S, Teng G, Dong J, Fan J. Zhou J, et al. Among authors: ren z. Liver Cancer. 2023 Apr 5;12(5):405-444. doi: 10.1159/000530495. eCollection 2023 Oct. Liver Cancer. 2023. PMID: 37901768 Free PMC article.
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial.
Llovet JM, Kudo M, Merle P, Meyer T, Qin S, Ikeda M, Xu R, Edeline J, Ryoo BY, Ren Z, Masi G, Kwiatkowski M, Lim HY, Kim JH, Breder V, Kumada H, Cheng AL, Galle PR, Kaneko S, Wang A, Mody K, Dutcus C, Dubrovsky L, Siegel AB, Finn RS; LEAP-002 Investigators. Llovet JM, et al. Among authors: ren z. Lancet Oncol. 2023 Dec;24(12):1399-1410. doi: 10.1016/S1470-2045(23)00469-2. Lancet Oncol. 2023. PMID: 38039993 Clinical Trial.
Oncolytic adenoviruses expressing checkpoint inhibitors for cancer therapy.
Xie D, Tian Y, Hu D, Wang Y, Yang Y, Zhou B, Zhang R, Ren Z, Liu M, Xu J, Dong C, Zhao B, Yang L. Xie D, et al. Among authors: ren z. Signal Transduct Target Ther. 2023 Nov 29;8(1):436. doi: 10.1038/s41392-023-01683-2. Signal Transduct Target Ther. 2023. PMID: 38016957 Free PMC article.
6,847 results